Arkolith/Insider Trading/VTGN/Form 4

Commodore Capital LP

10% OwnerVistagen Therapeutics, Inc. (VTGN) · full profile →Form 4 · filed Aug 9, 2023
Net Buying
Open-Market Buys
$18.0M
Open-Market Sells
$0
Net Open-Market Flow
$18.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 7, 2023Buy(P)776K$23.15$18.0M1.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-027352) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML